Intuitive Surgical Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Intuitive Surgical Inc 's ROA in the third quarter of 2026?
Intuitive Surgical Inc achieved a return on average assets (ROA) of 14.54 % in its third quarter of 2026, this is above ISRG's average return on assets of 14.44%.
Intuitive Surgical Inc s assets during the 12 months ending in the third quarter of 2026 are valued at $20 billion

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 66 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 355, from total ROA ranking in the second quarter of 2026 at 417.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	2.22 %	6.12 %	4.62 %	9.15 %	9.06 %
Y / Y Net Income Change	-26.28 %	23.94 %	17.38 %	16.21 %	24.29 %
Net Income (TTM) in million	2,972	3,158	2,999	2,877	2,765
Return On Assets (TTM)	14.54 %	15.53 %	14.98 %	14.53 %	14.27 %
ISRG's Total Ranking	# 355	# 417	# 386	# 385	# 396
Total Assets (TTM) in million	19,782	21,400	20,111	20,459	19,353
Seq. Total Assets Change	-7.56 %	6.41 %	-1.7 %	5.71 %	-4.03 %
Seq. Net Income Change	-36.49 %	-0.34 %	3.31 %	12.73 %	6.78 %

ISRG's 5 Years Annual ROA >> Back to ISRG Management Effectiveness >> Compare ISRG ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 16
Sector	# 67
Overall	# 357

Return On Assets Statistics
High	Average	Low
23.32 %	14.44 %	10.03 %
(March 31, 2007)		(Dec 31 2022)

Financial Statements
Intuitive Surgical Inc 's Assets	$ 19,782 million	ISRG's Balance sheet
Intuitive Surgical Inc 's Income	$ 523 million	Quarterly ISRG's Income Statement
ISRG's Income by Division		See ISRG's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	25.68 %	21.38 %	19.01 %	-4.28 %	21.36 %
Total Assets in million	23,558	18,744	15,442	12,975	13,555
Y / Y Net Income Change	23.06 %	28.62 %	35.18 %	-22.2 %	61.99 %
Net Income in million	2,877	2,338	1,817	1,344	1,728
Annual Return On Assets	12.21 %	12.47 %	11.77 %	10.36 %	12.75 %

ISRG's 5 Years Annual ROA >> Back to ISRG Management Effectiveness >> Compare ISRG ROA to its Competitors

Comment on ISRG's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 12.21 %, despite annual net income growth of 23.06 % to $2,876.60 million, from $2,337.50 million a year ago, as ISRG's assets increase to $23,557.90 million, by 23.06 %.

More Return On Assets Ratios
ISRG's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ISRG's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ISRG's Competitors
Subscribers only: Roa for Intuitive Surgical Inc 's Suppliers
Subscribers only: Return On Assets for ISRG's Customers

You may also want to know
ISRG's Roi	ISRG's Inventory Turnover Ratio	ISRG's Growth Rates	ISRG's Dividend Comparisons
	ISRG's Profitability Ratios	ISRG's Asset Turnover Ratio	ISRG's Dividend Growth
ISRG's Roe	ISRG's Valuation Ratios	ISRG's Financial Strength Ratios	ISRG's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Nurix Therapeutics Inc	38.61 %
Indivior Pharmaceuticals Inc	36.35 %
Rallybio Corporation	34.55 %
Idexx Laboratories Inc	34.05 %
Zevra Therapeutics Inc	26.33 %
Caredx Inc	25.74 %
Medpace Holdings Inc	24.47 %
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %

Date modified: 2026-10-22T05:13:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.